Praziquantel: all 37 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Different Treatment Frequencies for Hepatic Fibrosis Due to SchistosomiasisNot yet recruitingNCT07754617Phase 2/3
- Expanding Access to Preventive Chemotherapy Among Mobile and Migrant PopulationsRecruitingNCT07707817Not applicable
- Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal NeurocysticercosisNot yet recruitingNCT06376396Phase 4
- Bioequivalence Study of Coated Cesol Tablet Formulation Versus BiltricideCompletedNCT04314037Phase 1Results posted
- Praziquantel in Children Under Age 4CompletedNCT03640377Phase 2Results posted
- Praziquantel Bioequivalence StudyCompletedNCT03437447Phase 1Results posted
- An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)CompletedNCT02806232Phase 2Results posted
- Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy VolunteersCompletedNCT02325713Phase 1Results posted
- Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 YearsCompletedNCT02315352Phase 1Results posted
- Relative Bioavailability Trial of L-Praziquantel in Healthy VolunteersCompletedNCT02271984Phase 1Results posted
- S. Japonicum and Pregnancy OutcomesCompletedNCT00486863Phase 2Results posted
- Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)CompletedNCT00441285Phase 2/3Results posted
- Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African ChildrenStatus unknownNCT05354258Not applicable
- Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept StudyCompletedNCT04115072Phase 2/3
- Schistosomiasis Diagnosis Using a CAA Antigen TestStatus unknownNCT03779347Phase 3
- Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)TerminatedNCT02947581Phase 3
- Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital ImmunologyCompletedNCT02878564Phase 4
- Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)CompletedNCT02868385Phase 3
- Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisWithdrawnNCT02734186Phase 4
- Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?CompletedNCT02612896Not applicable
- Schistosoma Mansoni in Mwanza Region, TanzaniaCompletedNCT02162875Not applicable
- Arachidonic Acid Treatment Against Schistosomiasis Infection in ChildrenCompletedNCT02144389Not applicable
- Schistosoma Mansoni Morbidity in Children Aged 1-5 YearsCompletedNCT01901484Phase 2
- Schistosoma Haematobium Infections and PraziquantelCompletedNCT01558336Phase 3
- A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment OutcomesStatus unknownNCT01541631Not applicable
- Praziquantel-Pharmacokinetic StudyCompletedNCT01288872Phase 1
- Antioxidant Supplements in the Reversal of Schistosomal Peri-portal FibrosisStatus unknownNCT01260012Not applicable
- Safety and Efficacy of Drug Combinations Against Triple InfectionsCompletedNCT01050517Not applicable
- Safety and Efficacy of Drug Combinations Against SchistosomiasisCompletedNCT01050374Not applicable
- Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?TerminatedNCT00817713Not applicable
- Urogenital Schistosomiasis and Sexually Transmitted Infections in MadagascarCompletedNCT00713999Not applicable
- Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating SchistosomiasisCompletedNCT00510159Phase 2/3
- Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease ProgressionCompletedNCT00507221Not applicable
- Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in BrazilCompletedNCT00403611Phase 4
- Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, TanzaniaCompletedNCT00347113Not applicable
- Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in MozambiqueCompletedNCT00231322Not applicable
- The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, UgandaCompletedNCT00215267Not applicable